Certificates

Search by compound, report number or Sample ID. Public reports open directly; request-only documentation is supplied by support.

8 entries · 7 public reports · 1 on request

Reports by batch

Check the substance, linked products, batch number and report status. Measurements describe the tested sample; the link to delivered stock requires separate confirmation.

Report available

GLOW 70 mg

Batch number: 2505146
Report number: 209255
Niet vermeld · 70 mg

Report number: 209255

Batch number: 2505146

Laboratory: Janoshik

Analysis date: 2026-07-28

Sample label: 70 mg

Format: Not stated

Measured content: GHK-Cu: 36.90 mg (GHK: 32.26 mg; copper: 4.64 mg); TB-500 (889 Da): 8.91 mg; BPC-157: 9.85 mg

Documentation coverage: Linked products of the same substance, including their strength variants

Review: Not yet reviewed

Stock link for sampled variant: Current stock not confirmed

Measurements transcribed from the unchanged report for the tested sample. Documentation linked to GLOW vial and pen as instructed by Novogin. Product format and the link to current physical stock have not been confirmed. External report verification has not yet been performed.

Report on request

GOLD3 20 MG

Sample ID: NG-26-A041
Vial · 20 mg

Sample ID: NG-26-A041

Sample label: 20 mg

Format: Vial

Measured content: 21.66 mg

Purity: 99.741%

Documentation coverage: Linked products of the same substance, including their strength variants

Review: Not yet reviewed

Stock link for sampled variant: Current stock not confirmed

Data carried over from the existing documentation entry. The original report is available on request and its contents were not verified during this import. The physical batch number and its link to current stock have not yet been confirmed.

Under review — report available

MOTS-c 40 MG

Batch number: 2646902
Report number: 209256
Vial · 40 mg

Measured content: 17.98 mg
Discrepancy with sample label; under review.

Report number: 209256

Batch number: 2646902

Laboratory: Janoshik

Analysis date: 2026-07-27

Sample label: 40 mg

Format: Vial

Measured content: 17.98 mg

Purity: 98.267%

Documentation coverage: Linked products of the same substance, including their strength variants

Review: Under review

Stock link for sampled variant: Current batch confirmed

The report states 17.98 mg for a sample labelled 40 mg. This discrepancy has not yet been resolved. The report is under review and does not confirm a content of 40 mg. The original report is unchanged.

Report available

BPC-157 + TB-500 20 MG

Batch number: 2601228
Report number: 209254
Vial · 20 mg

Report number: 209254

Batch number: 2601228

Laboratory: Janoshik

Analysis date: 2026-07-28

Sample label: 20 mg

Format: Vial

Measured content: BPC-157: 10.85 mg; TB-500: 10.94 mg

Documentation coverage: Linked products of the same substance, including their strength variants

Review: Not yet reviewed

Stock link for sampled variant: Current stock not confirmed

Report available

GHK-Cu 50 MG

Batch number: 2609228
Report number: 211782
Vial · 50 mg

Report number: 211782

Batch number: 2609228

Laboratory: Janoshik

Analysis date: 2026-07-30

Sample label: 50 mg

Format: Vial

Measured content: 54.22 mg total (GHK: 44.99 mg; Cu: 9.23 mg)

Purity: 99.456%

Documentation coverage: Linked products of the same substance, including their strength variants

Review: Not yet reviewed

Stock link for sampled variant: Current stock not confirmed

Report available

Tesamorelin 10 MG

Batch number: 2601628
Report number: 211783
Vial · 10 mg

Report number: 211783

Batch number: 2601628

Laboratory: Janoshik

Analysis date: 2026-07-31

Sample label: 10 mg

Format: Vial

Measured content: 9.20 mg

Purity: 96.709%

Documentation coverage: Linked products of the same substance, including their strength variants

Review: Not yet reviewed

Stock link for sampled variant: Current stock not confirmed

Report available

CJC No DAC + Ipamorelin 10 MG

Batch number: 2608028
Report number: 211784
Vial · 5 mg + 5 mg

Report number: 211784

Batch number: 2608028

Laboratory: Janoshik

Analysis date: 2026-07-31

Sample label: 5 mg + 5 mg

Format: Vial

Measured content: CJC-1295 No DAC: 4.75 mg; Ipamorelin: 4.27 mg

Documentation coverage: Linked products of the same substance, including their strength variants

Review: Not yet reviewed

Stock link for sampled variant: Current stock not confirmed

Report available

NAD+ 500 MG

Batch number: 2611028
Report number: 211785
Vial · 500 mg

Report number: 211785

Batch number: 2611028

Laboratory: Janoshik

Analysis date: 2026-07-31

Sample label: 500 mg

Format: Vial

Measured content: 630.99 mg

Documentation coverage: Linked products of the same substance, including their strength variants

Review: Not yet reviewed

Stock link for sampled variant: Current stock not confirmed

Variants without a report

How to review a report

  1. Check the substance and linked products.
  2. Compare report and batch identifiers.
  3. Review the report image and analysis date.

Substance documentation can be linked to vial and pen formats and several strength variants. The measurements belong to the tested sample and do not automatically confirm the retail content, device characteristics or delivered batch of every format.

Browse documented research products